ILSI-Biomed Israel

ILSI-Biomed 2011: Israel’s Chief Scientist Reports a 430 million NIS Investment in Life Science Industries and Announces the Field as a Favored Sector

In 2010, the Israeli Chief Scientist approved a total of NIS 430 million in various program budgets. The R&D Committee alone considered 338 support applications from 193 companies for life science projects. 265 projects were approved for State assistance. Statistical reports prepared by the Israeli Chief Scientist office towards the ILSI – Biomed Israel 2011 Week, which will open in Tel Aviv next week (May 23-25, 2011), show that the Chief Scientist helped support life science projects in...

Looking for manager – pre clinical development

Looking for manager - pre clinical development • Design and execute pre-clinical studies (in vitro and in vivo) • Manage academic collaborators and CROs, including interactions with project managers, scientists, statisticians and contract departments • Write pre-clinical study protocols, reports and SOP • Report to VP R&D • At least 3 years experience as a scientific project manager in a biotech or pharmaceutical company • Proven experience in leading pre clinical activities includi...

BioView Ltd. Ranked in Top 50 Fastest Growing Israeli Technology Companies in Deloitte Survey

BioView Ltd. (TASE:BIOV) announced that it ranked as one of the 50 fastest growing technology companies in Israel. The Deloitte Technology Fast 50, one of the Israel's foremost technology award programs, is a ranking of the country's 50 fastest-growing technology companies based on percentage growth over five years. The Fast 50 program honors business growth, technological innovation and Israel entrepreneurial spirit. BioView’s automated scanning microscope and image analysis systems...

לחברת סטארט-אפ ביוטכנולוגית דרוש מנהל פיתוח

לחברת סטארט-אפ ביוטכנולוגית דרוש מנהל פיתוח *משרה בלעדית ודיסקרטית *סודיות מובטחת* :משרה מספר 8735 תאור המשרה ------------------------ לסטרט אפ בתחום הביוטכנולגיה דרוש מנהל פיתוח דרישות המשרה ------------------------ אנגלית ברמה ניסיון קודם כמנהל פיתוח בתחום רלוונטי בלבד ניסיון בפיתוח תהליכים ניסיון קודם בסביבת ייצור ניהול של בן אדם אחד אבל יגדל בהמשך. דרישות נוספות ------------------------ - יכולת למידה גבוהה - יסודיות - דומיננטיות - יכולת הובלה - הנעה פנ...

The new BioInform Magazine – a platform to connect

Two young Israeli scientists - Tal Shprung (M.Sc. in Biochemistry from the faculty of medicine, Tel-Aviv University) and  Alon Rayhman (M.Sc. from the Hebrew University, the faculty of agriculture) have come up with a unique idea for the biotech community in Israel: BioInform - a bio oriented magazine, that is aimed solely to the biotech community in Israel (pharmaceutical companies, medical device industry, biological facilities, academia institutions, ministerial offices and more). ...

May 23-25, 2011: save the date for ILSI-BioMed Israel!

Yes. It is about time to open your calendars and write down the next date: May 23-25 2011. ILSI-BioMed Israel 2011, that is. The 10th international Life Science & Technology Week is just around the corner. Time do flies... The event follows the highly successful 2010 BioMed conference which attracted more than 6000 participants from 51 countries. What an event! ILSI-BioMed 2011 will present high-quality program, featuring top-notch industry executives. Israel's most innovative medi...

Aiming for Near-Normal Blood Sugar Did Not Delay Combined Risk of Diabetic Damage for People With Long-standing Diabetes, NIH-Sponsored Trial Finds

In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found.  The intensive glucose treatment was compared with standard glucose control. These findings are from the NIH-funded Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.  Although intensive t...

ILSI-BioMed 2010 Has Begun!

This morning the ILSI-BioMed Week 2010 has finally been launched, with 7,000 anticipated participants that will take part in lectures and meetings with the experts and seniors of the bio-pharma and medical equipment industry in Israel and abroad. Following the opening words of the event's organizers, ILSI and Kenes, the president of Israel Shimon Peres came up to the stage and surveyed the future of Israel, which will be based on advanced technologies and serve as an example to the entire...

A French Delegation in the Negev

A French delegation has visited today (Sunday, 13.6.2010) at Ben-Gurion University, as the guest of Bio-Negev, the international center for innovation in the biotechnology industry and life sciences in the Negev. The purpose of the visit is to examine potential collaboration between the visitors and the new initiative in the Negev, BGU being one of the partners in the project. Prof. Rivka Carmi, president of the university, places a great amount of value in the initiative, which can be direct...

Stem Cells as Seek-and-Destory Missiles against Cancer

As published in New Scientist, stem cells were succesfully modified to act as seek-and-destroy missiles against cancer in mice brains Stem cells are often viewed as the ultimate solution for regenerative medicine, and for a good cause. Given the correct cues, they can regenerate whole parts of the body, and even re-create an entire embryo (although that would require QUITE some understanding of the cues involved in the process). It seems, however, that now a new use has been found for the...